Literature DB >> 3720388

Sleep arterial oxygen desaturation and chemical control of breathing during wakefulness in COPD.

K Tatsumi, H Kimura, F Kunitomo, T Kuriyama, S Watanabe, Y Honda.   

Abstract

Recent studies have demonstrated that oxygen desaturation occurs during sleep in some patients with chronic obstructive pulmonary disease (COPD). The degree of sleep hypoventilation in COPD may be related to an inadequate chemical control of ventilation. To investigate this relationship, we compared maximal sleep changes in arterial oxygen saturation (SaO2) with the hypercapnic and hypoxic ventilatory control during wakefulness in 24 patients with COPD. Both hypercapnic and hypoxic ventilatory responses were inversely correlated with the degree of maximal sleep desaturation in rapid-eye-movement (REM) sleep. Furthermore, the level of baseline SaO2 during wakefulness was also negatively related to the magnitude of sleep desaturation. Patients with insufficient chemical control of breathing appear to have larger falls in SaO2, particularly if they have lower baseline SaO2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720388     DOI: 10.1378/chest.90.1.68

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  Respiratory depression and spinal opioids.

Authors:  R C Etches; A N Sandler; M D Daley
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

2.  Nocturnal oxygen therapy in patients with chronic obstructive pulmonary disease: a survey of Canadian respirologists.

Authors:  Yves Lacasse; Frédéric Sériès; Sylvie Martin; François Maltais
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

3.  Blunted ventilatory response to hypoxia/hypercapnia in mice with cigarette smoke-induced emphysema.

Authors:  F Xu; J Zhuang; R Wang; J C Seagrave; T H March
Journal:  Respir Physiol Neurobiol       Date:  2007-04-08       Impact factor: 1.931

4.  Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease.

Authors:  Y F Heijdra; P N Dekhuijzen; C L van Herwaarden; H T Folgering
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

5.  Effects of acetazolamide in patients with the sleep apnoea syndrome.

Authors:  H Tojima; F Kunitomo; H Kimura; K Tatsumi; T Kuriyama; Y Honda
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

6.  Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Authors:  Yves Lacasse; Sarah Bernard; Frédéric Sériès; Van Hung Nguyen; Jean Bourbeau; Shawn Aaron; François Maltais
Journal:  BMC Pulm Med       Date:  2017-01-09       Impact factor: 3.317

Review 7.  Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.

Authors:  Carlos Zamarrón; Vanesa García Paz; Emilio Morete; Felix del Campo Matías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 8.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.